Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.2041
H.R.2041: To suspend temporarily the duty on the production of anti-cancer drugs.
About This Bill
- This bill was introduced in the 105th Congress
- This bill is primarily about health
- Introduced June 25, 1997
- Latest Major Action July 2, 1997
Bill Sponsor
Bill Summary
Amends the Harmonized Tariff Schedule of the United States to suspend, through December 31, 2000, the duty on (S)-N-((5-(2-(2-amino- 4,6,7,8-tetra-hydro-4-oxo-1H-pyrimido(5,4-b) (1,4)thiazin-6-yl)ethyl)- 2-thieny-l)carbonyl)-L-glutamic acid diethyl ester (anti-cancer drug).
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Referred to the House Committee on Ways and Means.
|
|
Referred to the Subcommittee on Trade.
|
|
See H.R.2622.
|
|
June 25, 1997 |
Introduced in the House by Robert T. Matsui (D-Calif.) |